Project Manager (UCL CAR-T Programme)

The Cancer Research UK & UCL Cancer Trials Centre (CTC) is a UKCRC registered and NCRI Clinical Trials Unit group member: https://www.ctc.ucl.ac.uk/ It is one of the largest cancer trials centres in the UK, with more than 115 members of staff managing >80 research studies.

The CTC conducts clinical studies in oncology, both nationally and internationally, with a cross-disciplinary approach to evaluate anti-cancer treatments, and investigate methods of diagnosis and early detection.

CRUK & UCL Cancer Trials Centre - Mission Statement:

• Work with national investigators, patients and charities, and other stakeholders to develop biomarker led studies offering personalised therapies to improve outcomes for patients, and to improve detection and early diagnosis

• To translate basic science discoveries and hypotheses into early phase clinical trials of biotherapeutics and advanced radiation therapy as an integral part of the CRUK City of London Centre and linked CRUK research programmes

• Deliver practice changing trials and advanced therapy trials: phase I-III

• Ensure that we work with our Patient and Public Involvement and Engagement members to develop streamlined protocols that build in the needs of diverse and disadvantaged populations with all our trials.

The Project Manager will help monitor the CAR-T cell clinical trial development programme from late pre-clinical, through grant funding to trial delivery (in adult and paediatric cancers). He/she will be associated with the whole portfolio (rather than a specific trial, for which there is already a study management team within the CTC).

The post holder will work with a dedicated team of trial coordinators and senior trial coordinators specialised in T cell based immunotherapies including CAR-T cells (ATIMP).

The post is funded for one year in the first instance.

The post holder will have a demonstrable track record in project management and experience/knowledge of conducting clinical trials of investigational drugs/products, including knowledge of GCP, pharmacovigilance, the UK Medicines for Human Use (Clinical Trial) Regulations, and ethics.

Experience in immunology research (preferentially cellular therapy) would be advantageous.

As well as the exciting opportunities this role presents, we also offer some great benefits some of which are below:

• 41 Days holiday (27 days annual leave 8 bank holiday and 6 closure days)

• Additional 5 days’ annual leave purchase scheme

• Defined benefit career average revalued earnings pension scheme (CARE)

• Cycle to work scheme and season ticket loan

• Immigration loan

• On-Site nursery

• On-site gym

• Enhanced maternity, paternity and adoption pay

• Employee assistance programme: Staff Support Service

• Discounted medical insurance

Visit https://www.ucl.ac.uk/work-at-ucl/reward-and-benefits to find out more.

The CTC also offers hybrid working - with staff being able to work flexibly between our office and home (usually minimum 40% FTE office based work) - along with UCL core hours and flexible start/finish times.

Our department holds an Athena SWAN Silver award, in recognition of our commitment and demonstrable impact in advancing gender equality.

As London’s Global University, we know diversity fosters creativity and innovation, and we want our community to represent the diversity of the world’s talent.

We are committed to equality of opportunity, to being fair and inclusive, and to being a place where we all belong. We therefore particularly encourage applications from candidates who are likely to be underrepresented in UCL’s workforce. These include people from Black, Asian and ethnic minority backgrounds; disabled people; LGBTQI+ people; and for our Grade 9 and 10 roles, women.